YAYüksel Altuntaş

Yüksel Altuntaş

*This is an algorithmically generated author record based on publicly available information.

Yüksel Altuntaş has a total of 140 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Genetic spectrum and genotype–phenotype associations in Paget's disease of bone: A nationwide multicenter study from Türkiye

    by Dilek Gogas Yavuz, Hazal Şalva, Pınar Ata, Ebru Arslan, Onur Hanoğlu, Mahsan Azimi, Zeliha Hekimsoy, Hakan Doğruel, Ramazan Sarı, Feyza Yener Öztürk, et al.

  • Open Access

    Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Significance of Pre-Transplant Controlling Nutritional Status Score

    by Sıdıka Gülkan Özkan, Suna Avcı, Ali Kimiaei, Seyedehtina Safaei, Yüksel Altuntaş, Aslı Yüksel Öztürkmen, Zeynep Aslı Durak, Sinem Özdemir, Mohammad Adeeb Abbara, Tuğba Ağyol, et al.

    Nutritional status is an important prognostic factor in patients with multiple myeloma (MM). The Controlling Nutritional Status (CONUT) score has shown promise in predicting outcomes in various malignancies; however, its role in autologous stem cell transplantation (ASCT) in patients with MM remains unclear. This study aimed to evaluate the significance of pre-transplant CONUT scores in predicting post-transplant engraftment kinetics and early complications in patients with MM undergoing ASCT. This single-center, retrospective study analyzed 59 multiple myeloma patients who underwent ASCT between 1 October 2022, and 1 July 2024. Pre-transplant CONUT scores were calculated, and their associations with various post-transplant outcomes were assessed using statistical analyses. Higher CONUT scores were independently associated with longer neutrophil engraftment times (p = 0.012). Patients who developed oral mucositis (OM) had significantly higher CONUT scores than those without OM (p = 0.028). A CONUT score cut-off of 2.5 demonstrated 100% sensitivity and 57.14% specificity in predicting OM (Area Under the Curve (AUC) 0.792, 95% CI: 0.654–0.930, p = 0.033). Our study demonstrates that a higher pre-transplant CONUT score is significantly associated with a delay in neutrophil engraftment and an increased risk of developing oral mucositis. These findings suggest that the CONUT score can serve as a valuable predictive tool for early post-transplant complications, thereby guiding targeted interventions and improving patient management.


  • Erişkin Bağışıklama: Şişli Hamidiye Etfal Hastanesi Örneği

    by Seda Özmen Sever, Güzin Zeren Öztürk, Beray Gelmez Taş, Yüksel Altuntaş, Dilek Yıldız Sevgi, Özgür Yiğit


  • Lateralization outcomes of bilateral inferior petrosal sinus sampling: desmopressin vs CRH

    by Buruc Erkan, Mehmet Said Cil, Mehmet Cingoz, Sebnem Burhan, Seyma Aksoy, Sabahattin Yuzkan, Ebubekir Akpinar, Suat Demir, Osman Tanriverdi, Burak Kocak, et al.

    Purpose Bilateral inferior petrosal sinus sampling (BIPSS) is the gold standard for localizing ACTH-dependent Cushing’s syndrome (CS). While corticotropin-releasing hormone (CRH) was initially used for stimulation, desmopressin has become a common alternative. This research evaluates desmopressin’s effectiveness in lateralizing Cushing’s disease (CD) during BIPSS compared to CRH stimulation. Methods The study included 33 individuals with ACTH-dependent CS who underwent BIPSS and had diagnoses confirmed by endoscopic endonasal transsphenoidal pituitary surgery (EETPS). Fourteen participants underwent BIPSS with CRH and 19 with desmopressin. A comparative analysis was conducted. Results BIPSS accurately lateralized 76% of cases, specifically, 71% with CRH and 79% with desmopressin (p = 0.2). For tumors < 6 mm on MRI, overall accuracy was 82%, namely, 75% with CRH and 90% with desmopressin (p = 0.4). IPSS achieved 100% accuracy in the four cases with no lesion on preoperative MRI. Conclusion This study demonstrates no significant difference in lateralization accuracy between desmopressin and CRH for IPSS. In challenging cases, especially those with microadenomas or non-lesional CD, desmopressin with IPSS aids in preoperative lateralization.


  • Comparison of Two Estimated Glucose Disposal Rate Methods for Detecting Insulin Resistance in Adults with Type 1 Diabetes Mellitus

    by Muhammed Masum Canat, Yüksel Altuntaş

    Background: The presence of insulin resistance (IR) in patients with type 1 diabetes mellitus (T1DM) is a significant indicator of all chronic diabetic complications, independent of other risk factors. The estimated glucose disposal rate (eGDR) is a practical method that can be easily used in daily practice to determine IR. This study aimed to determine the cutoff values for two eGDR methods and compare their diagnostic value for determining IR in adult T1DM patients with metabolic syndrome (MetS). Methods: This cross-sectional study was performed on 184 adults admitted to the endocrinology outpatient clinic diagnosed with T1DM. Demographic characteristics, anthropometric measurements, and the presence of hypertension (HT) were recorded. The eGDR of all patients was calculated using two formulas based on HbA1c level, presence of HT, waist-to-hip ratio (WHR), or waist circumference (WC). Diagnostic cutoff values for both eGDRs were defined using receiver operating characteristic (ROC) analysis. Patients were divided into two groups according to the cutoff values. The accuracy of the diagnostic cutoffs for eGDRwhr and eGDRwc was compared using a Bland-Altman plot. Results: The cutoff value for eGDRwhr was 7.37 mg/(kg·min) with 83.3% specificity and 86.7% sensitivity [area under the curve (AUC) = 0.901; P < 0.001; 95% confidence interval (CI), 0.824-0.977] and for eGDRwc 7.50 mg/(kg·min) with 79.8% specificity and 83.3% sensitivity (AUC = 0.895; P < 0.001; 95% CI, 0.817-0.972) for the presence of MetS. Further ROC analysis showed that the difference between the two AUCs (0.901 and 0.895) was not significant (P = 0.923). Conclusion: Assessment of eGDR would lead to early prevention of diabetic complications. eGDR is measured using either WHR or WC. This study is the first to compare WHR and WC in calculating eGDR in adults. WHR and WC are not superior to each other for calculating eGDR in determining IR in T1DM.


  • Retrospective Analysis of Factors Impairing Glycemic Control in Type 2 Diabetics on Intensive Insulin Therapy with HbA1c Levels of 10% or Above (Single-Center Experience)

    by Serpil Yanık Çolak, Yüksel Altuntaş

    Objectives: In this study, we aimed to investigate the effects of factors related to lifestyle, treatment compliance, and eating habits on blood glucose regulation in patients diagnosed with Type 2 DM (Diabetes Mellitus) with HbA1c 10% and above who are receiving intensive insulin therapy. Methods: The study sample consisted of 100 diabetic patients with inadequate glycemic control who applied to our clinic between January 2015 and December 2016. A questionnaire developed by the researchers was used in the study. The patients' sociodemographic and anthropometric characteristics, eating habits, compliance with insulin treatment, physical activity, and dental health data were documented. Results: Of the patients included in our study, 75% were female and 25% were male, the average age was 60, the average HbA1c was 12.3%, and the average Body Mass Index was 31.7 kg/m2. While 88% of our patients stated that they had three main meals a day, 12% stated that they skipped at least one main meal, and 64% had irregular eating habits. Forty percent of our patients skipped insulin doses at least 1-2 times a week, and there was a statistically significant relationship between the frequency of insulin dose skipping and HbA1c subgroups (p=0.014). Sixty-seven percent of our patients did not exercise daily. Conclusion: Although education level, eating habits, exercise, and dental health are among the variables affecting glycemic control in diabetic patients, the most critical factor affecting glycemic control in our study group was a lack of compliance with insulin injection.

  • Open Access

    The effects of adequate dietary calcium intake in patients with hypoparathyroidism non-adherent to treatment: a prospective randomized controlled trial

    by Muhammed Masum Canat, Adnan Batman, Çiğdem Dönmez, Hatice Köstek, Mehmet Köstek, Zeynep Mine Yalçınkaya Kara, Feyza Yener Öztürk, Yüksel Altuntaş

    A significant problem that compels clinicians in the conventional treatment of hypoparathyroidism is patients’ non-adherence to treatment. This study aimed to evaluate the effects of adequate Ca intake with dietary recommendations among hypoparathyroidism patients who persistently use Ca supplementation irregularly on plasma Ca and phosphate levels.


  • Open Access

    Risk Factors, Use of Preventive Drugs, and Cardiovascular Events in Diabetes Mellitus: The PURE Türkiye Cohort

    by Aytekin Oguz, Mustafa Kilickap, Sadi Gulec, Yueksel Altuntas, Kubilay Karsidag, Ahmet Temizhan, Ozge Telci Caklili, K. Burcu Tumerdem Calik, Mirac Vural Keskinler, Sumathy Rangarajan, et al.

    Background: The risk of cardiovascular disease is correlated with the frequency and control of associated risk factors in diabetes mellitus and may vary according to country. We evaluated risk factors for cardiovascular disease, cardiovascular events, and the use of preventive medications in patients with diabetes mellitus using the Prospective Urban and Rural Epidemiological Turkiye cohort.Methods: Patients with diabetes mellitus versus without diabetes mellitus were com- pared for risk factors, cardioprotective drugs (angi otens in-co nvert ing enzyme inhibitors or angiotensin-II receptor antagonists, statins, and antiplatelets), and cardiovascular events. The primary outcome was major cardiovascular events (composite of cardiovas- cular death, myocardial infarction, stroke, or heart failure).Results: Among 4041 participants, 549 (13.6%) had diabetes mellitus. The mean age (54.8 & PLUSMN;8.4 vs. 49.3 & PLUSMN; 9.0 years, P < .001) and proportion of women (65.4% vs. 59.9%, P = .014) were higher in diabetics compared with non-diabetics. Hypertension, history of coronary heart disease, and use of statin, antiplatelets, and angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists were more common in diabetics; however, the use of these medications at baseline was lower than optimal even in patients with diabetes mellitus and concomitant coronary heart disease (statin 31.2%, antiplatelets 46.9%, and angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists 54.7%). During 11.5 years of follow-up, major cardiovascular events occurred in 288 (7.1%) patients, and the risk was higher in diabetics [hazard ratio (95% confidence interval) 1.71 (1.30-2.24); P < .001]. The increase in the risk of future events was comparable for those with diabetes mellitus alone without cardiovascular disease [hazard ratio 1.62 (1.20-2.20)] versus those with cardiovascular disease alone without diabetes mellitus [hazard ratio 1.31 (0.83-2.07)] and was additive in those with both conditions [hazard ratio 2.79 (1.65-4.69)]. The risk of major coronary events (myocardial infarction, angina, percutaneous, or surgical coronary intervention) was also higher in diabetes mellitus [hazard ratio 1.64 (1.26-2.15); P < .001].Conclusion: Patients with diabetes mellitus have a higher risk of major cardiovascular events, and the risk is comparable to that observed in those with cardiovascular disease but no diabetes mellitus. The use of preventive medicines for cardiovascular diseases is disturbingly low in diabetics.


  • Open Access

    The Effect of Diabetes Mellitus on Mortality in Patients Hospitalized Intensive Care Unit in Covid-19 Pandemic

    by Nermin Balta Başı, Seyhan Metin, Sultan Acar Sevinç, Aysel Salkaya, Nebia Peker, Ayşe Surhan Çınar, Yüksel Altuntaş, Hacı Mustafa Özdemir

    There are many studies on the effects of Diabetes Mellitus on the clinical course in COVID-19 patients. Factors that increase the risk of contracting COVID-19 disease and increase disease progression have been caused, and diabetes mellitus is one of them. We aimed to evaluate the incidence of Diabetes Mellitus in patients treated in the intensive care unit in respiratory failure due to COVID-19 pneumonia, and the effect of Diabetes Mellitus on the length of stay in intensive care and mortality. Our study is a single-center retrospective study. The study includes patients hospitalized in our COVID intensive care unit between March 16, 2019, and May 16, 2020 Patients over 18 years of age with and without a history of Diabetes Mellitus were compared in 2 groups. Demographic data of the patients, length of stay in the intensive care unit, respiratory support methods, presence of other comorbid diseases, effects of Diabetes Mellitus to mortality in ICU were recorded. The information of 150 patients was obtained in the COVID-19 intensive care units of our hospital. Diabetes Mellitus was detected in 49 of the patients hospitalized in intensive care. 34.7% of these patients were female and 65.3% were male. There was no significant difference in survival in both groups (p = 0.942). The BMI of the patients with Diabetes Mellitus was 27.07 ± 2.55, significantly higher (p = 0.005). Intensive care stay periods were similar in both groups. The presence of hypertension was significantly higher in those with Diabetes Mellitus (p = 0.000). There was no statistically significant difference between respiratory support methods. Diabetes Mellitus did not affect the duration of stay in the intensive care unit and mortality in patients who were followed up and treated in the intensive care unit due to COVID-19 pneumonia. (www.actabiomedica.it)